180 related articles for article (PubMed ID: 9873535)
21. Efficient synthesis of an enantiopure beta-lactam as an advanced precursor of thrombin and tryptase inhibitors.
Annunziata R; Benaglia M; Cinquini M; Cozzi F; Maggioni F; Puglisi A
J Org Chem; 2003 Apr; 68(7):2952-5. PubMed ID: 12662075
[TBL] [Abstract][Full Text] [Related]
22. Noncovalent inhibition of the serine proteases, alpha-chymotrypsin and trypsin by trifluoro(organo)borates.
Smoum R; Rubinstein A; Srebnik M
Org Biomol Chem; 2005 Mar; 3(5):941-4. PubMed ID: 15731882
[TBL] [Abstract][Full Text] [Related]
23. 3,8-Diazabicyclo[3.2.1]octan-2-one peptide mimetics: synthesis of a conformationally restricted inhibitor of farnesyltransferase.
Dinsmore CJ; Bergman JM; Bogusky MJ; Culberson JC; Hamilton KA; Graham SL
Org Lett; 2001 Mar; 3(6):865-8. PubMed ID: 11263902
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase.
Jiang S; Li P; Lee SL; Lin CY; Long YQ; Johnson MD; Dickson RB; Roller PP
Org Lett; 2007 Jan; 9(1):9-12. PubMed ID: 17192072
[TBL] [Abstract][Full Text] [Related]
25. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
Karle M; Knecht W; Xue Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
[TBL] [Abstract][Full Text] [Related]
26. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM
J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
Miyazaki Y; Kato Y; Manabe T; Shimada H; Mizuno M; Egusa T; Ohkouchi M; Shiromizu I; Matsusue T; Yamamoto I
Bioorg Med Chem Lett; 2006 Jun; 16(11):2986-90. PubMed ID: 16540315
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of lysine-containing sulphonium salts and their properties as proteinase inhibitors.
Rauber P; Walker B; Stone S; Shaw E
Biochem J; 1988 Mar; 250(3):871-6. PubMed ID: 2968789
[TBL] [Abstract][Full Text] [Related]
29. Azetidin-2-one derivatives as inhibitors of thrombin.
Han WT; Trehan AK; Wright JJ; Federici ME; Seiler SM; Meanwell NA
Bioorg Med Chem; 1995 Aug; 3(8):1123-43. PubMed ID: 7582985
[TBL] [Abstract][Full Text] [Related]
30. Peptidyl human heart chymase inhibitors. 2. Discovery of highly selective difluoromethylene ketone derivatives with Glu at P3 site.
Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
Bioorg Med Chem Lett; 1998 Apr; 8(8):919-24. PubMed ID: 9871512
[TBL] [Abstract][Full Text] [Related]
31. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
32. Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
Sutton JC; Bolton SA; Davis ME; Hartl KS; Jacobson B; Mathur A; Ogletree ML; Slusarchyk WA; Zahler R; Seiler SM; Bisacchi GS
Bioorg Med Chem Lett; 2004 May; 14(9):2233-9. PubMed ID: 15081015
[TBL] [Abstract][Full Text] [Related]
33. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE
J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of potent and selective 2-azepanone inhibitors of human tryptase.
Zhao G; Bolton SA; Kwon C; Hartl KS; Seiler SM; Slusarchyk WA; Sutton JC; Bisacchi GS
Bioorg Med Chem Lett; 2004 Jan; 14(2):309-12. PubMed ID: 14698147
[TBL] [Abstract][Full Text] [Related]
35. Benzoxazin-4-ones as novel, easily accessible inhibitors for rhomboid proteases.
Yang J; Barniol-Xicota M; Nguyen MTN; Ticha A; Strisovsky K; Verhelst SHL
Bioorg Med Chem Lett; 2018 May; 28(8):1423-1427. PubMed ID: 29506958
[TBL] [Abstract][Full Text] [Related]
36. Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl group.
Costanzo MJ; Maryanoff BE; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Kauffman JA; Lewis JM; Krishnan R; Tulinsky A
J Med Chem; 1996 Aug; 39(16):3039-43. PubMed ID: 8759623
[No Abstract] [Full Text] [Related]
37. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
Ganesh V; Lee AY; Clardy J; Tulinsky A
Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of potent and highly selective inhibitors of human tryptase.
Slusarchyk WA; Bolton SA; Hartl KS; Huang MH; Jacobs G; Meng W; Ogletree ML; Pi Z; Schumacher WA; Seiler SM; Sutton JC; Treuner U; Zahler R; Zhao G; Bisacchi GS
Bioorg Med Chem Lett; 2002 Nov; 12(21):3235-8. PubMed ID: 12372541
[TBL] [Abstract][Full Text] [Related]
39. Bound structures of novel P3-P1' beta-strand mimetic inhibitors of thrombin.
St Charles R; Matthews JH; Zhang E; Tulinsky A
J Med Chem; 1999 Apr; 42(8):1376-83. PubMed ID: 10212123
[TBL] [Abstract][Full Text] [Related]
40. Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease.
Dhanak D; Burton G; Christmann LT; Darcy MG; Elrod KC; Kaura A; Keenan RM; Link JO; Peishoff CE; Shah DH
Bioorg Med Chem Lett; 2000 Oct; 10(20):2279-82. PubMed ID: 11055338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
